NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the "Class Period"), of the important June 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased GoodRx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

In 2013, the average stock price was in the range of $30-50. With inflation and rapidly rising valuations, the stock market is getting quite expensive for the everyday investor. While cheap stocks do exist, many carry risks that larger blue chip stocks don't. This is due to a smaller market cap and higher general volatility. Also, the fact that due to their smaller size, macroeconomic events affect them much more than they affect larger companies. Let's explore three cheap stocks that could help your portfo ...

NEW YORK, June 4, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GoodRx investors who were adversely affected by alleged securities fraud between September 23, 2022 and November 8, 2022. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/goodrx-lawsuit-submission ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, inclusive (the "Class Period"). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exch ...

RADNOR, Pa., June 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). This action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was fi ...

Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GoodRx common stock between September 23, 2020 and November 8, 2022, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/GDRX. NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationa ...

NEW YORK, May 30, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GoodRx investors who were adversely affected by alleged securities fraud between September 23, 2022 and November 8, 2022. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/goodrx-lawsuit-submission ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of GoodRx Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's revenue sources and business operations [1][2]. Group 1: Allegations - The complaint alleges that during the class period from September 23, 2022, to November 8, 2022, GoodRx misrepresented its reliance on Kroger, which accounted for nearly 25% of its total prescription transactions revenue despite representing less than 5% of pharmacies accepting GoodRx discounts [1]. - It is claimed that Kroger had the ability to unilaterally stop accepting GoodRx discounts, which could significantly impact GoodRx's revenue from Kroger pharmacies [1]. - The allegations suggest that the defendants' statements regarding GoodRx's business, operations, and future prospects were materially false and misleading, lacking a reasonable basis [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares of GoodRx during the specified class period are encouraged to register for the class action by June 21, 2024, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

RADNOR, Pa., May 27, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). his action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was filed in ...

No fewer than five analysts have lifted their price target in the last week GoodRx Holdings Inc (NASDAQ:GDRX) stock is on the rise today, after an upgrade from RBC to "outperform" from "market perform," with a price-target hike to $10 from $8. This is just the latest in a string of bull notes for the stock, as GDRX has received five price-target hikes since a Raymond James upgrade a week ago. At last glance, GoodRx stock was up 2% at $7.35, earlier as high as $7.80. The equity has been trading choppily, wit ...